Browsing by Subject "Pre-exposure prophylaxis (PrEP)"

Fale com a Fiocruz

Fundação Oswaldo Cruz

Now showing items 1-14 of 14

Ambulatory and hospitalized patients with suspected and confirmed mpox: an observational cohort study from Brazil

Silva, Mayara Secco Torres et al. | Date Issued: 2023
Ambulatory and hospitalized patients with suspected and confirmed mpox: an observational cohort study from Brazil

Silva, Mayara Secco Torres et al. | Date Issued: 2023
Association of age, baseline kidney function, and medication exposure with declines in creatinine clearance on pre-exposure prophylaxis: an observational cohort study

Gandhi, Monica et al. | Date Issued: 2016
Estradiol and Spironolactone Plasma Pharmacokinetics Among Brazilian Transgender Women Using HIV Pre‑Exposure Prophylaxis: Analysis of Potential Interactions

Cattani, Vitória Berg et al. | Date Issued: 2023
Features of HIV Infection in Long-Acting Cabotegravir PreExposure Prophylaxis

Landovitz, Raphael J. et al. | Date Issued: 2024
Features of HIV Infection in Long-Acting Cabotegravir PreExposure Prophylaxis

Landovitz, Raphael J. et al. | Date Issued: 2024
Food insecurity directly impacts adherence to antiretroviral therapy and to pre-exposure prophylaxis among sexual and gender minorities in Brazil

Luz, Paula Mendes et al. | Date Issued: 2024
Impact of feminizing hormone therapy on tenofovir and emtricitabine plasma pharmacokinetics: a nested drug-drug interaction study in a cohort of Brazilian transgender women using HIV pre-exposure prophylaxis

Cattani, Vitória Berg et al. | Date Issued: 2022
Impact of pre-exposure prophylaxis uptake among gay, bisexual, and other men who have sex with men in urban centers in Brazil: a modeling study

Luz, Paula M. et al. | Date Issued: 2023
New HIV prevention approaches: promise, praxis, and pitfalls

Mayer, Kenneth H. et al. | Date Issued: 2022
Performance characteristics of HIV RNA screening with long-acting injectable cabotegravir (CAB-LA) pre-exposure prophylaxis (PrEP) in the multicenter global HIV Prevention Trials Network 083 (HPTN 083) Study

Landovitz, Raphael et al. | Date Issued: 2024
Proactive strategies to optimize engagement of Black, Hispanic/Latinx, transgender, and nonbinary individuals in a trial of a novel agent for HIV pre-exposure prophylaxis (PrEP)

Cespedes, Michelle et al. | Date Issued: 2022
The rising tide of HIV among young men who have sex with men in Brazil: insights from the Conectad@s study

Jalil, Cristina M. et al. | Date Issued: 2024
Same-day initiation of oral pre-exposure prophylaxis among gay, bisexual, and other cisgender men who have sex with men and transgender women in Brazil, Mexico, and Peru (ImPrEP): a prospective, single-arm, open-label, multicentre implementation study

Veloso, Valdiléa G. et al. | Date Issued: 2023